Shenzhen Beike Biotechnology is a stem cell research organization in Shenzhen, China. It focuses on adult stem cell research, banking, and immunotherapy. The facility was founded in July 2005. It runs over 20 laboratories that follow GMP standards. Every stem cell package has a unique traceability code. The team has treated over 33,500 patients from more than 60 countries.

For cerebral palsy patients, the clinic reports 88% physical improvement. Success rates for spinal muscular atrophy include 95% quality-of-life improvement. The facility holds ISO 9001 and ISO 17025 certifications. Its inspection center was the first adult stem cell lab accredited by CNAS. The team has published nearly 50 peer-reviewed papers in journals like Nature.